To ask the Secretary of State for Health what estimate he has made of the proportion of females aged over 15 years who have received protection by vaccination against (a) cervical cancer and (b) genital warts.

By 31 August 2011, we estimate 1.1 million females aged 16 or older in England had received the full course of the human papillomavirus (HPV) vaccine (Cervarix®) that provides protection against cervical cancer. This is the vaccine offered in the routine HPV immunisation programme.

Data on the number of females that have received the HPV vaccine (Gardasil®), that also provides protection against genital warts, are not held centrally.